A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis

NCT03373695 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary In-stent Restenosis

Interventions

DEVICE: Dissolve™
DEVICE: SeQuent®Please

Sponsor

DK Medical Technology (Suzhou) Co., Ltd.

Collaborators

[object Object]